Hepatobiliary cancer

Highly lethal cancers that include the hepatocellular carcinomas, gallbladder and bile duct cancers, both intrahepatic and extrahepatic cholangiocarcinomas.

Gall bladder cancer and cholangiocarcinoma are collectively known as biliary tract cancer.

In 2017 an estimated 40,710 people in the US will be diagnosed with liver cancer and intrahepatic bile duct cancer, and additional 10,310 people will be diagnosed with gallbladder cancer or other biliary tract cancer.

In 2014 an estimated 23,000 deaths from liver or intrahepatic bile duct cancer will occur.

The incidence and mortality rates for liver cancer are increasing.

In 2014 an estimated 3630 deaths from gallbladder cancer or other biliary tract cancer.

Hepatobiliary cancer accounts for approximately 2.4% of all cancer diagnoses.

Hepatobiliary cancers are almost 3 times more common in men than women with age adjusted

rates of 13.3 versus 4.6 new cases per hundred thousand persons.

Hepatobiliary cancers are only rarely seen in younger persons, with the median age of diagnosis of 63 years.

Patients 54 years or younger account for 16.6% of all cases.

Leave a Reply

Your email address will not be published. Required fields are marked *